Navigation Links
Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
Date:6/8/2011

BYETTA was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program. BYETTA is not insulin and should not be taken instead of insulin. BYETTA is not currently recommended to be taken with insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis. BYETTA has not been studied in people who have pancreatitis.

BYETTA provides sustained A1C control and low incidence of hypoglycemia when used alone or in combination with metformin or a thiazolidinedione, with potential weight loss (BYETTA is not a weight-loss product). BYETTA was approved in the U.S. in April 2005 and in Europe in November 2006 and has been used by more than 1.8 million patients since its introduction. See important safety information below. Additional information about BYETTA is available at http://www.byetta.com/.

Important Safety Information for BYETTA® (exenatide) injection

Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Patients should be observed for signs and symptoms of pancreatitis after initiation or dose escalation of BYETTA. The risk for getting low blood sugar is higher if BYETTA is taken with another medicine that can cause low blood sugar, such as a sulfonylurea. BYETTA should not be used in people who have severe kidney problems and should be used with caution in people who have had a kidney transplant. Patients should
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
2. Lilly Comments on Court Ruling in Amylin Litigation
3. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
4. Lilly Provides Its Perspective in Response to Amylin Lawsuit
5. Lilly Provides Statement in Response to Amylin Lawsuit
6. Amylin Pharmaceuticals Files Suit Against Eli Lilly
7. JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes
8. Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference
9. Amylin Pharmaceuticals to Present at the Deutsche Bank 36th Annual Healthcare Conference
10. Amylin Pharmaceuticals Reports First Quarter Financial Results
11. Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 3, 2015 Today, the ... Internet. As markets become ever more transparent, the importance ... AG recognised long ago. Its maxim of "innovation brings ... networking and digitisation. The company has long ... "state of the art" technology and modern approach, while ...
(Date:6/2/2015)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... of products for the treatment of central nervous system ... M.D., Vanda,s President and CEO, will deliver a corporate ... New York City on Thursday, June ... The presentation at the Jefferies Global Healthcare Conference will ...
(Date:6/2/2015)... N.C. , June 2, 2015 Kewaunee ... Board of Directors declared a quarterly cash dividend of ... 2015 to stockholders of record at the close of ... Kewaunee Scientific Founded in 1906, Kewaunee Scientific ... manufacture, and installation of laboratory, healthcare, and technical furniture ...
Breaking Medicine Technology:
... Sweden, September 1 Calabar AB, a privately,held ... announced a EUR 350,000 equity financing from the ... Calabar,s product,through a phase II study with repeated ... drug on the minor glands will lead to ...
... 1 Biosensors,International Group, Ltd ("Biosensors", "Company"), ... drug-eluting stent,developed by Biosensors, has demonstrated equal ... Johnson,s industry leading drug-eluting stent, CYPHER,SELECT(TM) ("Cypher"), ... The results of the landmark study were ...
Cached Medicine Technology:Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study 3
(Date:6/3/2015)... These are challenging and unpredictable times for ... of digital-first business are rewriting the rules for business ... need for traditional businesses to take on a more ... their services. On top of this there is ... start-ups, to bring new innovation and approaches to business. ...
(Date:6/3/2015)... First Choice Emergency Room , ... the United States, announced that it is opening its ... , “I am pleased to announce that we ... facility in the San Antonio area,” said Dr. James ... Room. , First Choice Emergency Room is revolutionizing ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... 03, 2015 Foot and Ankle ... Casey Friske ( Clarksville Division ) was recently ... Symposium of Advanced Wound Care (SAWC) and the American ... Dan Davis. The Conference was held on April ... Center in San Antonio, TX. , Dr. Casey ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Veatch Consulting ... Satisfaction. Since they first opened for business in April ... service the needs of their clients. Each and every ... Veatch Dental Consulting is proud to say that they ... , A new feature recently added this year is ...
Breaking Medicine News(10 mins):Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3
... ... ... ... ...
... NC A novel technology for delivering nicotine to the ... the habit. When compared to the nicotine vapor ... proved more effective at delivering nicotine to the blood stream. ... according to Duke University Medical Center researchers. Users also reported ...
... against trying on your own , SATURDAY, Feb. ... way for children with serious peanut allergies, with two ... kids, tolerance over time. , Both studies were small, ... on peanut-allergic children whose immune systems were prompted to ...
... ... faculty and staff, a seven-member team of community college administrators from across ... for GateWay Community College. The news was announced at an exit meeting ... Rebecca Nickoli talked of how the team saw firsthand the college,s "engagement ...
... ... addition of Garrett and Sylvia McGrath, top earners in the network marketing industry and ... ... -- EvolvHealth LLC http://EvolvHealth.com announced today the addition of Garrett and Sylvia ...
... ... ... , , ... ...
Cached Medicine News:Health News:American Red Cross Responds Internationally and at Home to Chile Quake 2Health News:American Red Cross Responds Internationally and at Home to Chile Quake 3Health News:American Red Cross Responds Internationally and at Home to Chile Quake 4Health News:American Red Cross Responds Internationally and at Home to Chile Quake 5Health News:American Red Cross Responds Internationally and at Home to Chile Quake 6Health News:New smoking cessation therapy proves promising 2Health News:Kids' Peanut Allergies Might Be Tamed: Study 2Health News:Kids' Peanut Allergies Might Be Tamed: Study 3Health News:Kids' Peanut Allergies Might Be Tamed: Study 4Health News:GateWay Community College Receives Strong Endorsement for Re-accreditation 2Health News:GateWay Community College Receives Strong Endorsement for Re-accreditation 3Health News:Why Leading Network Marketers Garrett and Sylvia McGrath Joined EvolvHealth LLC 2Health News:Why Leading Network Marketers Garrett and Sylvia McGrath Joined EvolvHealth LLC 3Health News:Doctors Applaud Latest Furlough Reversal 2Health News:Doctors Applaud Latest Furlough Reversal 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: